A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects
| Status: | Recruiting |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/2/2016 |
| Start Date: | January 2015 |
| Contact: | Eric P Hoffman, PhD |
| Email: | ericphoffman@gmail.com |
| Phone: | 202-476-6011 |
A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects
The purpose of this study is to examine the safety, tolerability, and PK of various
increasing single and multiple doses of VBP15 in healthy adult subjects.
increasing single and multiple doses of VBP15 in healthy adult subjects.
Inclusion Criteria:
- For the SAD component: Male subjects, ages 18 to 65 years, inclusive.
- For the MAD component: Male subjects or female subjects of nonchildbearing potential
ages 18 to 65, inclusive.
Exclusion Criteria:
- For the MAD: Women of childbearing potential.
- Clinically significant abnormal laboratory parameters
We found this trial at
1
site
Click here to add this to my saved trials
